0001179110-17-004432.txt : 20170310
0001179110-17-004432.hdr.sgml : 20170310
20170310170819
ACCESSION NUMBER: 0001179110-17-004432
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170301
FILED AS OF DATE: 20170310
DATE AS OF CHANGE: 20170310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Michael Robert A.
CENTRAL INDEX KEY: 0001699914
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 17683013
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
3
1
edgar.xml
FORM 3 -
X0206
3
2017-03-01
0
0001551152
AbbVie Inc.
ABBV
0001699914
Michael Robert A.
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
VP, Controller
Common stock, $0.01 par value
21838
D
Option (right to buy)
54.86
2026-02-17
Common stock
10140
D
Option (right to buy)
61.36
2018-02-16
2027-02-15
Common stock
11420
D
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 3,380 shares on 2/18/2017, and becomes exercisable as to 3,380 shares on 02/18/2018, and 3,380 shares on 02/18/2019.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 3,807 shares on 02/16/2018, 3,806 shares on 02/16/2019, and 3,807 shares on 02/16/2020.
Steven L. Scrogham, attorney-in-fact for Robert A. Michael
2017-03-10